BioNTech's revenue forecasts have been downgraded, with earn...
BioNTech's revenue forecasts have been downgraded, with earnings outlook slashed from profit to loss. The company's revenues are expected to underperform the wider industry, leading to increased pessimism about the business's intrinsic value.
BioNTech SE Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment